Topic
MedTech
Johnson & Johnson Q3 Earnings Surpass Estimates
Johnson & Johnson beat third-quarter adjusted earnings estimates despite a significant drop in net profit driven by a multi-billion-dollar talc litigation charge.
Johnson & Johnson beat third-quarter adjusted earnings estimates despite a significant drop in net profit driven by a multi-billion-dollar talc litigation charge.